Search Within

Mark E Robson

Formats
  1. Journal Article (383)
  2. Meeting Abstract (262)
  3. Review (11)
  4. Book Section (7)
  5. Guidelines (7)
  6. Editorial (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (682)
  2. Department of Medicine (682)
  3. Population Sciences Research Program (682)
  4. Solid Tumor Oncology Division (682)
  5. Survivorship Research (682)
  6. GSK Faculty (379)

More Groups

People
  1. Kenneth Offit (280)
  2. Zsofia Stadler (116)
  3. Larry Norton (90)
  4. Vijai Joseph (79)
  5. Diana Mandelker (74)
  6. Michael Berger (67)

More People

Years
  1. 2025 (7)
  2. 2024 (33)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (19)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (188)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Oxford University Press (43)
  6. Elsevier Inc. (42)

More Publishers

Results (682)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differences between screen-detected and interval breast cancers among BRCA mutation carriers
    Meeting Abstract

    Pilewskie, M. L.; Zabor, E. C.; Stempel, M.; Petruolo, O.; Mangino, D.; Robson, M. E.; Jochelson, M. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of actionable cancer predisposing germline mutations in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)
    Meeting Abstract

    Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Examining patients' medical and psychosocial experiences following detection of a CDH1 variant with multiplex genetic testing
    Meeting Abstract

    Hamilton, J.; Long, J. M.; Brandt, A. C.; Brower, J.; Symecko, H.; Salo-Mullen, E. E.; Christian, S.; Couch, F.; Garber, J. E.; Offit, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • DNA damage repair (DDR) germline mutations in patients (Pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Carlo, M. I.; Vijai, J.; Mandelker, D.; Kemel, Y.; Regazzi, A. M.; Zhang, L.; Stadler, Z. K.; Walsh, M. F.; Cadoo, K. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline genetic alterations in colorectal cancer patients
    Meeting Abstract

    Cercek, A.; Kemel, Y.; Mandelker, D.; Stewart, C.; Arnold, A. G.; Sheehan, M.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Saltz, L. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Work status after treatment for breast cancer: A controlled, prospective, longitudinal study of an ethnically diverse cohort
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Eberle, C. E.; Jung, G.; Kampel, L. J.; Hwang, C.; Bao, T.; Robson, M. E.; Malik, M.; Gany, F.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients
    Meeting Abstract

    Bao, T.; Seidman, A. D.; Piulson, L.; Chen, X.; Vickers, A. J.; Vertosick, E.; Blinder, V. S.; Zhi, W. I.; Li, Q. S.; Vahdat, L. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Selecting patients with triple negative breast cancer for platinum-based therapy: We still haven't found what we're looking for
    Journal Article

    Robson, M.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • OlympiAD final overall survival: Olaparib versus chemotherapy treatment of physician's choice (TPC) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm)
    Meeting Abstract

    Robson, M. E.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Armstrong, A.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save